Anavex Compound to be Tested in Biogen Neurological Protection Model
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Biogen Agreement Further Validates Anavex Life Sciences (AVXL) AV2-73 - FBR
September 28, 2016 10:39 AM EDTFBR Capital analyst Christopher James weighed in on Anavex Life Sciences (NASDAQ: AVXL) after the company announced that it has signed a material transfer agreement with Biogen under which Biogen will test AV2-73 in a validated preclinical CNS assay. As a... More
Anavex Life Sciences (AVXL) Surges Higher; Stock Up 47%
September 28, 2016 10:12 AM EDTAnavex Life Sciences (NASDAQ: AVXL) surges to highs following this morning's testing deal with Biogen (NASDAQ: BIIB). Shares are up 46.8% on volume that is 37x normal.
... More